FDA endorses Pfizer’s COVID-19 vaccine for children 5-11
FDA’s panel of experts endorsed the Pfizer-BioNTech COVID-19 vaccine for kids ages 5 to 11, a key step in making the shots more widely available for younger children.
FDA’s panel of experts endorsed the Pfizer-BioNTech COVID-19 vaccine for kids ages 5 to 11, a key step in making the shots more widely available for younger children.